Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Completed · Phase 1
Conditions studied: Distress, Depression, Grief
In brief
The purpose of this study is to determine whether psilocybin-assisted group psychotherapy is a safe and feasible treatment for demoralization in long-term AIDS survivors (LTAS).
Key facts
- Study ID
- NCT02950467
- Run by
- Joshua Woolley
- People needed
- 30
- Starts
- 2018-01-05
- Expected to finish
- 2019-12-31
- Last updated by the study team
- 2021-01-07
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- A physical, neurological or cognitive condition that makes participating in the study unsafe or unfeasible.
- Regular psychotropic medication use.
- Personal or family history of serious mental illness.
- Severe depression requiring immediate standard-of-care treatment.
- Exclusion by the clinical judgment of the study investigators.
Where it is running
- University of California, San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.